Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections
NCT00004996 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2019-12-12
Summary
This study will compare the structure, chemical composition and other characteristics of skin and blood in people with and without parasitic infections. Cell samples will be taken from blisters produced by suction blistering. This study may provide new information about the interactions between parasites and the immune system that could lead to better treatments for these infections.
Normal volunteers and patients with acute helminth (a type of parasite) infections aged 18 years older may be eligible for this study. Following a medical history and physical exam, participants will undergo suction blistering to provide cells needed for study. A suction blister device is attached to the skin of the thigh. A heating element in the device heats the skin to speed blister formation. (This will feel only a slightly warm.) The device is removed after about two hours, when the blisters have formed. The blister tops are removed with sterile scissors. The blistered areas are then treated with special dressings to promote healing and the participant is discharged with further wound care instructions. A small amount of blood (around four tablespoons) may be drawn to compare chemicals in the blood with chemicals in the blister fluid. Participants will be contacted by telephone over the next 72 hours to check on healing. Further follow-up will occur by phone at 6 months and 1 year.
Up to 60 blisters may be produced over a one-year period (in three separate sessions every six months) with no more than 20 raised per session....
Conditions
- Healthy
- Helminthiasis
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Thomas B Nutman, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-03-20
- Completion
- 2015-04-22
Countries
- United States
Study Locations
More Related Trials
-
The Human Microbiome in Immune-Mediated Diseases
NCT02394964 ·Status: COMPLETED
-
Role of Tzanck Smear in Determining Pemphigus Vulgaris Disease Activity
NCT05338112 ·Status: UNKNOWN
-
Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis
NCT03259230 ·Status: COMPLETED
-
Study of Mast Cell Precursors
NCT00001756 ·Status: COMPLETED
-
A Study of Bermekimab in Patients With Hidradenitis Suppurativa
NCT03512275 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
NCT04204616 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
NCT01211977 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris
NCT04023149 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic Lymphohistiocytosis
NCT06047210 ·Status: COMPLETED
-
Platelet Activation in Chronic Inflammatory Skin Diseases
NCT01759693 ·Status: UNKNOWN
-
Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid
NCT02874079 ·Status: UNKNOWN ·Phase: NA
-
Interest of Flow Cytometry for the Diagnosis, the Follow up and Specific Immunotherapy (SIT) Arrest of Hymenoptera Venom Allergy
NCT00805402 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
NCT04021862 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TAK-881 in Healthy Adults
NCT05059977 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses
NCT04549792 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
NCT07256392 ·Status: RECRUITING ·Phase: PHASE3
-
Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid
NCT06479018 ·Status: RECRUITING ·Phase: NA
-
Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
NCT00001761 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations
NCT00004694 ·Status: COMPLETED ·Phase: NA
-
Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic Rhinitis
NCT02908360 ·Status: COMPLETED
-
A Study of CDX-0159 in Patients With Chronic Inducible Urticaria
NCT05405660 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
NCT05368285 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study in Adults Sensitized to Cat
NCT00689299 ·Status: COMPLETED ·Phase: PHASE2
-
Study of IFN-K in Dermatomyositis
NCT02980198 ·Status: WITHDRAWN ·Phase: PHASE2
-
Interleukin-2 for Refractory Chronic Spontaneous Urticaria
NCT06924762 ·Status: RECRUITING ·Phase: PHASE2/PHASE3